National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

D-cycloserine
An analogue of the amino acid D-alanine with broad-spectrum antibiotic and glycinergic activities. D-cycloserine interferes with bacterial cell wall synthesis by competitively inhibiting two enzymes, L-alanine racemase and D-alanine:D-alanine ligase, thereby impairing peptidoglycan formation necessary for bacterial cell wall synthesis. This agent may be bactericidal or bacteriostatic, depending on its concentration at the infection site and the susceptibility of the organism. In addition, D-cycloserine is an excitatory amino acid and partial agonist at the glycine binding site of the NMDA receptor in the central nervous system (CNS); binding to the central NMDA receptor may result in amelioration of neuropathic pain. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Oxamycin
Tisomycin
US brand name:Seromycin
Chemical structure names:
  • (+)-4-Amino-3-isoxazolidinone
  • 3-Isoxazolidinone, 4-amino-, d-



Previous:cytokine-induced killer cells, cytomegalovirus pp65-specific cytotoxic T lymphocytes, Cytomel, Cytosar-U, Cytoxan
Next:D-methionine formulation MRX-1024, D1/3-MAGE-3-His fusion protein, DAB389 epidermal growth factor, dacarbazine, dacetuzumab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov